Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Oncoimmunology|July 4, 2012
Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?Andrea Facciabene, Stephen Santoro, George CoukosHuman Gene Therapy|January 10, 2013
Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibitionDe-Gang Song, Qunrui Ye, Stephen Santoro, et al.Cancer Immunology, Immunotherapy : CII|December 10, 2016
Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapyXiaopeng Yuan, Mingjuan Yang, Xiang Chen, et al.Cancer Immunology, Immunotherapy : CII|January 10, 2018
Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapyXiaopeng Yuan, Mingjuan Yang, Xiang Chen, et al.Cancer Immunology Research|September 30, 2018
FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast TumorsViviana Cremasco, Jillian L Astarita, Angelo L Grauel, et al.Nature|February 15, 2018
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cellsSanjeev Mariathasan, Shannon J Turley, Dorothee Nickles, et al.Pageof 1